Literature DB >> 2473568

Risk/benefit of treating retroperitoneal teratoid bulky tumors.

N Jaeger1, L Weissbach, J H Hartlapp, W Vahlensieck.   

Abstract

Inductive polychemotherapy of germinal cell tumors in advanced stages (T0-4N3M0,1) is effective, yet accompanied by serious side effects. Partial remission necessitates resection of the residual tumor. The complications of the salvage operation are tolerable in proportion to its curativity. In a retrospective analysis, we evaluated the occurrence of toxic side effects and the frequency of intra- and postoperative complications in 128 patients with retroperitoneal teratoid bulky tumor. With a follow-up of three to one hundred ten months (means = 43 months), 91 patients (71%) are alive without evidence of disease; 28 patients (22%) died of apparent tumor progression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473568     DOI: 10.1016/0090-4295(89)90148-9

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  2 in total

1.  Vascular considerations in postchemotherapy. Retroperitoneal lymph-node dissection: Part II.

Authors:  J P Donohue; J A Thornhill; R S Foster; R Bihrle
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

2.  Vascular considerations in postchemotherapy. Retroperitoneal lymph-node dissection: Part I--Vena cava.

Authors:  J P Donohue; J A Thornhill; R S Foster; R Bihrle
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.